XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
3 Months Ended
Mar. 31, 2023
Cash and Cash Equivalents [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 9. STOCKHOLDERS’ EQUITY

 

Restricted Stock

 

On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 442,248 shares of restricted stock to non-executive directors at a value of $1.29 per share. As of December 31, 2022, 110,562 shares of common stock remained unissued; these shares were issued during the three months ended March 31, 2023.

 

On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 172,000 shares of restricted stock to non-executive directors at a value of $7.66 per share. As of December 31, 2021, 43,000 shares of common stock remained unissued; these shares were issued during the three months ended March 31, 2022.

 

Series H Convertible Preferred Stock

 

 

      
Number of Series H Preferred Stock outstanding as of March 31, 2023   8 
Multiplied by the stated value  $154 
Equals the gross stated value  $1,232 
Divided by the conversion price  $184.8 
Equals the convertible shares of Company common stock   7 
Multiplied by the fair market value of Company common stock as of March 31, 2023  $0.55 
Equals the payment  $4 

 

 

Series H-3 Convertible Preferred Stock

 

 

      
Number of Series H-3 Preferred Stock outstanding as of March 31, 2023   1,234 
Multiplied by the stated value  $138 
Equals the gross stated value  $170,292 
Divided by the conversion price  $165.6 
Equals the convertible shares of Company common stock   1,028 
Multiplied by the fair market value of Company common stock as of March 31, 2023  $0.55 
Equals the payment  $565 

 

Series H-6 Convertible Preferred Stock

 

 

      
Number of Series H-6 Preferred Stock outstanding as of March 31, 2023   50 
Multiplied by the stated value  $72 
Equals the gross stated value  $3,600 
Divided by the conversion price  $2.5 
Equals the convertible shares of Company common stock   1,440 
Multiplied by the fair market value of Company common stock as of March 31, 2023  $0.55 
Equals the payment  $792 

 

Warrants

 

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

 

   Shares Underlying Warrants   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (in years) 
Outstanding at December 31, 2022   6,106,023   $7.30    1.32 
Granted   -    -      
Exercised   -    -      
Expired   (78,355)   11.29      
Outstanding at March 31, 2023   6,027,668   $7.25    1.09